Literature DB >> 15016884

Effects of mutations of the initiation nucleotides on hepatitis C virus RNA replication in the cell.

Zhaohui Cai1, T Jake Liang, Guangxiang Luo.   

Abstract

Replication of nearly all RNA viruses depends on a virus-encoded RNA-dependent RNA polymerase (RdRp). Our earlier work found that purified recombinant hepatitis C virus (HCV) RdRp (NS5B) was able to initiate RNA synthesis de novo by using purine (A and G) but not pyrimidine (C and U) nucleotides (G. Luo et al., J. Virol. 74:851-863, 2000). For most human RNA viruses, the initiation nucleotides of both positive- and negative-strand RNAs were found to be either an adenylate (A) or guanylate (G). To determine the nucleotide used for initiation and control of HCV RNA replication, a genetic mutagenesis analysis of the nucleotides at the very 5' and 3' ends of HCV RNAs was performed by using a cell-based HCV replicon replication system. Either a G or an A at the 5' end of HCV genomic RNA was able to efficiently induce cell colony formation, whereas a nucleotide C at the 5' end dramatically reduced the efficiency of cell colony formation. Likewise, the 3'-end nucleotide U-to-C mutation did not significantly affect the efficiency of cell colony formation. In contrast, a U-to-G mutation at the 3' end caused a remarkable decrease in cell colony formation, and a U-to-A mutation resulted in a complete abolition of cell colony formation. Sequence analysis of the HCV replicon RNAs recovered from G418-resistant Huh7 cells revealed several interesting findings. First, the 5'-end nucleotide G of the replicon RNA was changed to an A upon multiple rounds of replication. Second, the nucleotide A at the 5' end was stably maintained among all replicon RNAs isolated from Huh7 cells transfected with an RNA with a 5'-end A. Third, initiation of HCV RNA replication with a CTP resulted in a >10-fold reduction in the levels of HCV RNAs, suggesting that initiation of RNA replication with CTP was very inefficient. Fourth, the 3'-end nucleotide U-to-C and -G mutations were all reverted back to a wild-type nucleotide U. In addition, extra U and UU residues were identified at the 3' ends of revertants recovered from Huh7 cells transfected with an RNA with a nucleotide G at the 3' end. We also determined the 5'-end nucleotide of positive-strand RNA of some clinical HCV isolates. Either G or A was identified at the 5' end of HCV RNA genome depending on the specific HCV isolate. Collectively, these findings demonstrate that replication of positive-strand HCV RNA was preferentially initiated with purine nucleotides (ATP and GTP), whereas the negative-strand HCV RNA replication is invariably initiated with an ATP.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15016884      PMCID: PMC371060          DOI: 10.1128/jvi.78.7.3633-3643.2004

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  59 in total

Review 1.  De novo initiation of viral RNA-dependent RNA synthesis.

Authors:  C C Kao; P Singh; D J Ecker
Journal:  Virology       Date:  2001-09-01       Impact factor: 3.616

2.  Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome.

Authors:  Q L Choo; G Kuo; A J Weiner; L R Overby; D W Bradley; M Houghton
Journal:  Science       Date:  1989-04-21       Impact factor: 47.728

3.  A mechanism for initiating RNA-dependent RNA polymerization.

Authors:  S J Butcher; J M Grimes; E V Makeyev; D H Bamford; D I Stuart
Journal:  Nature       Date:  2001-03-08       Impact factor: 49.962

4.  Effect of alpha interferon on the hepatitis C virus replicon.

Authors:  J T Guo; V V Bichko; C Seeger
Journal:  J Virol       Date:  2001-09       Impact factor: 5.103

5.  Hepatitis C virus shares amino acid sequence similarity with pestiviruses and flaviviruses as well as members of two plant virus supergroups.

Authors:  R H Miller; R H Purcell
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

6.  De novo synthesis of minus strand RNA by the rotavirus RNA polymerase in a cell-free system involves a novel mechanism of initiation.

Authors:  D Chen; J T Patton
Journal:  RNA       Date:  2000-10       Impact factor: 4.942

7.  Template requirements for RNA synthesis by a recombinant hepatitis C virus RNA-dependent RNA polymerase.

Authors:  C C Kao; X Yang; A Kline; Q M Wang; D Barket; B A Heinz
Journal:  J Virol       Date:  2000-12       Impact factor: 5.103

8.  Template requirement and initiation site selection by hepatitis C virus polymerase on a minimal viral RNA template.

Authors:  J W Oh; G T Sheu; M M Lai
Journal:  J Biol Chem       Date:  2000-06-09       Impact factor: 5.157

9.  Template/primer requirements and single nucleotide incorporation by hepatitis C virus nonstructural protein 5B polymerase.

Authors:  W Zhong; E Ferrari; C A Lesburg; D Maag; S K Ghosh; C E Cameron; J Y Lau; Z Hong
Journal:  J Virol       Date:  2000-10       Impact factor: 5.103

10.  Efficient initiation of HCV RNA replication in cell culture.

Authors:  K J Blight; A A Kolykhalov; C M Rice
Journal:  Science       Date:  2000-12-08       Impact factor: 47.728

View more
  16 in total

1.  Evidence that the polymerase of respiratory syncytial virus initiates RNA replication in a nontemplated fashion.

Authors:  Sarah L Noton; Vanessa M Cowton; Chadene R Zack; David R McGivern; Rachel Fearns
Journal:  Proc Natl Acad Sci U S A       Date:  2010-05-17       Impact factor: 11.205

2.  Mechanistic characterization of the 5'-triphosphate-dependent activation of PKR: lack of 5'-end nucleobase specificity, evidence for a distinct triphosphate binding site, and a critical role for the dsRBD.

Authors:  Rebecca Toroney; Chelsea M Hull; Joshua E Sokoloski; Philip C Bevilacqua
Journal:  RNA       Date:  2012-08-21       Impact factor: 4.942

3.  Robust production of infectious hepatitis C virus (HCV) from stably HCV cDNA-transfected human hepatoma cells.

Authors:  Zhaohui Cai; Chen Zhang; Kyung-Soo Chang; Jieyun Jiang; Byung-Chul Ahn; Takaji Wakita; T Jake Liang; Guangxiang Luo
Journal:  J Virol       Date:  2005-11       Impact factor: 5.103

4.  Masking the 5' terminal nucleotides of the hepatitis C virus genome by an unconventional microRNA-target RNA complex.

Authors:  Erica S Machlin; Peter Sarnow; Selena M Sagan
Journal:  Proc Natl Acad Sci U S A       Date:  2011-01-10       Impact factor: 11.205

5.  MicroRNA-122 antagonism against hepatitis C virus genotypes 1-6 and reduced efficacy by host RNA insertion or mutations in the HCV 5' UTR.

Authors:  Yi-Ping Li; Judith M Gottwein; Troels K Scheel; Tanja B Jensen; Jens Bukh
Journal:  Proc Natl Acad Sci U S A       Date:  2011-03-07       Impact factor: 11.205

6.  An in vitro model of hepatitis C virion production.

Authors:  Theo Heller; Satoru Saito; Jonathan Auerbach; Tarice Williams; Tzivia Rachel Moreen; Allison Jazwinski; Brian Cruz; Neha Jeurkar; Ronda Sapp; Guangxiang Luo; T Jake Liang
Journal:  Proc Natl Acad Sci U S A       Date:  2005-02-08       Impact factor: 11.205

Review 7.  cis-Acting RNA elements in the hepatitis C virus RNA genome.

Authors:  Selena M Sagan; Jasmin Chahal; Peter Sarnow
Journal:  Virus Res       Date:  2015-01-07       Impact factor: 3.303

8.  Replication of hepatitis C virus (HCV) RNA in mouse embryonic fibroblasts: protein kinase R (PKR)-dependent and PKR-independent mechanisms for controlling HCV RNA replication and mediating interferon activities.

Authors:  Kyung-Soo Chang; Zhaohui Cai; Chen Zhang; Ganes C Sen; Bryan R G Williams; Guangxiang Luo
Journal:  J Virol       Date:  2006-08       Impact factor: 5.103

9.  Repair and polyadenylation of a naturally occurring hepatitis C virus 3' nontranslated region-shorter variant in selectable replicon cell lines.

Authors:  Hans C van Leeuwen; Jolanda M P Liefhebber; Willy J M Spaan
Journal:  J Virol       Date:  2006-05       Impact factor: 5.103

10.  Evidence for Internal Initiation of RNA Synthesis by the Hepatitis C Virus RNA-Dependent RNA Polymerase NS5B In Cellulo.

Authors:  Philipp Schult; Maren Nattermann; Chris Lauber; Stefan Seitz; Volker Lohmann
Journal:  J Virol       Date:  2019-09-12       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.